NCT05163223 2024-06-17
Cornerstone001
Aston Sci. Inc.
Phase 2 Terminated
Clinical Trials
4 trialsNCT02978222 2022-12-15
Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer
Marker Therapeutics, Inc.
Phase 2 Terminated
NCT01403285 2014-05-19
Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma
Immatics Biotechnologies GmbH
Phase 1 Terminated
NCT00308087 2013-12-27
PREMIER
Sanofi
Phase 2 Terminated